Echinacea purpurea 1200 mg
Natural health product licensed in Canada
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Dioxyde de silicium, Stéarate de magnésium, Acide stéarique, Phosphate de dicalcium dihydraté, Cellulose microcristalline, Poly(éthylène glycol), Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1 Capsule ; maximum: 2 Capsule | 4 Tous les jours |
Uses authorised in Canada
Utilisée traditionnellement en phytothérapie pour aider à combattre les infections, particulièrement les infections des voies respiratoires supérieures et à soulager les symptômes du rhume.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Si les symptômes persistent ou s'aggravent, consulter un praticien de soins de santé. Si vous prenez des immunosuppresseurs, consulter un praticien de soins de santé avant d'en faire l'usage. Si vous souffrez d'une maladie auto-immune, consulter un praticien de soins de santé avant d'en faire l'us. Si vous souffrez d'une maladie systémique progressive telle que la tuberculose, la collagénose, la sclérose en plaques, le sida et/ou une infection au VIH, consulter un praticien de soins de sante avant d'en faire l'usage.
- Effets indésirables connus
Des cas rares de réactions allergiques sévères peuvent se manifester; faire preuve de prudence si vous êtes allergique aux plante de la famille des Marguerites.
Product record
- Licence holder
- BIOVANTEK
- NPN or DIN-HM
- 80088519
- Status
- Inactive licence
- Licence date
- 1 October 2018
- Revision date
- 17 March 2021
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
Source
Official Health Canada record, licence 80088519
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.